Incidence, Severity, and Outcomes of AKI Associated with Dual Renin-Angiotensin System Blockade-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Incidence, Severity, and Outcomes of AKI Associated with Dual Renin-Angiotensin System Blockade

Published:2016-09-27 Issue:11 Volume:11 Page:1944-1953
ISSN:1555-9041
Container-title:Clinical Journal of the American Society of Nephrology
language:en
Short-container-title:CJASN

Author:

Palevsky Paul M.,Zhang Jane H.,Seliger Stephen L.,Emanuele Nicholas,Fried Linda F.

Publisher

American Society of Nephrology (ASN)

Subject

Transplantation,Nephrology,Critical Care and Intensive Care Medicine,Epidemiology

Reference29 articles.

1. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL

3. The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy

4. Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

5. Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of chronic kidney disease: a Hong Kong consensus recommendation;Hong Kong Medical Journal;2024-08-27

2. Efficacy and safety of dual renin–angiotensin system (RAS) blockade for non-elderly diabetic kidney disease patients with preserved eGFR;International Urology and Nephrology;2024-07-17

3. Cardiorenal effects of dual blockade with Angiotensin-converting enzyme inhibitors and Angiotensin receptor blockers in people with CKD: analysis of routinely collected data with emulation of a reference trial (ONTARGET);2024-05-28

4. Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease;Cochrane Database of Systematic Reviews;2024-04-29

5. The therapeutic effect of mesenchymal stem cells in diabetic kidney disease;Journal of Molecular Medicine;2024-02-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3